Jan 27, 2023 · 1h 38m · allin

E113: DOJ tries to break up Google, vaccine questions, Ukraine escalation & more

David Friedberg · 27m spoken Chamath Palihapitiya · 23m spoken David Sacks · 22m spoken Jason Calacanis · 11m spoken Albert Bourla · 1s spoken Outro Song Vocalist · 1s spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In Episode 113 of the All-In Podcast, hosts Jason Calacanis, Chamath Palihapitiya, David Sacks, and David Friedberg analyze the DOJ antitrust lawsuit against Google, Microsoft's enterprise bundling practices, COVID-19 vaccine safety data and mandates, escalating military support for Ukraine, and groundbreaking longevity research.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 98.9% of the talking time here. How this is scored →

The hosts as informed peer 7.7 Guest teaching 5.5 Guest disagreement 3.8 The hosts pushing back 5.3
05100:0020:0040:001:00:001:20:002:51–6:56 · The hosts as informed peer 8/10 DOJ Lawsuit to Break Up Google's Ad Tech Business Chamath details digital ad market shares (Google 26.5%, Meta 18.4%, Amazon 11.7%, Others 43.4%), contrasting Google's position with Ma Bell's 1980s 100% monopoly to argue the DOJ lawsuit is ill-founded. Sacks moderates by raising the antitrust filing, while Chamath provides detailed market analysis.6:56–12:12 · The hosts as informed peer 9/10 Friedberg's Analysis of Google's Auction Model & Publisher Payouts Friedberg draws on his AdSense and AdWords experience since 2002 to explain how Google's auction model and 70-80% publisher revenue share prevent monopoly rents. Sacks uses a DOJ diagram to probe sell-side vs buy-side market concentration.12:12–15:16 · The hosts as informed peer 6/10 Government Unwinding Decade-Old Deals & Impact on M&A Calacanis, Sacks, and Chamath critique the DOJ trying to unwind DoubleClick fifteen years post-acquisition, noting it creates market uncertainty and chills tech M&A.15:16–17:53 · The hosts as informed peer 8/10 Shifting Ad Market Dynamics: Amazon, Third-Party Cookies & Apple IDFA Friedberg outlines how Amazon's e-commerce ad growth, Apple's IDFA deprecation, and 2024 third-party cookie removal are naturally decentralizing ad spend. Chamath highlights these shifts as evidence of dynamic market self-regulation.17:53–23:07 · The hosts as informed peer 7/10 Monopolistic Targets: App Store Duopolies vs. Regulatory Misdirection Chamath forcefully pushes back when Calacanis draws an analogy to Xi Jinping and Jack Ma, calling out Calacanis for virtue signaling about China. Sacks and Chamath argue regulators should focus on true duopolies like Apple and Google's app stores.23:07–25:37 · The hosts as informed peer 8/10 EU Antitrust Probe into Microsoft Teams & Slack's Complaint Chamath shares insider perspective from his time on Slack's board during its IPO, explaining how Microsoft Teams used distribution bundling to counter Slack's superior product. Sacks introduces the EU antitrust probe into Microsoft bundling.25:37–29:41 · The hosts as informed peer 7/10 Predatory Bundling, ELAs & Sacks' Unbundling Proposal Sacks argues Microsoft's enterprise bundling degrades startup moats in B2B software, while Chamath suggests regulatory transparency for Enterprise Licensing Agreements (ELAs). Calacanis questions whether consumers suffer actual harm.29:41–33:38 · The hosts as informed peer 7/10 The Software Dumping Debate: Free Market vs. Antitrust Protections Friedberg strongly rejects Sacks' framing that bundling constitutes software dumping, arguing that superior differentiated software will win regardless of discounts. Sacks counters that software reverse engineering makes bundling inherently predatory.33:38–38:03 · The hosts as informed peer 8/10 SaaS Innovation Moats & The Comcast / Netflix Analogy Chamath challenges Friedberg using a Comcast and Netflix analogy to show how distribution rails can smother application innovation. Sacks compares software bundling to Chinese steel dumping to justify regulatory oversight.38:03–40:34 · The hosts as informed peer 8/10 Practical Regulatory Remedies for B2B Software Markets Chamath outlines regulatory remedies including transfer-pricing transparency and sum-of-the-parts pricing rules, drawing parallels to Pfizer's healthcare R&D accounting mandates.40:34–44:24 · The hosts as informed peer 6/10 Pfizer CEO Albert Bourla Confronted at Davos by Rebel News Sacks plays a video clip of a Rebel News reporter aggressively questioning Pfizer CEO Albert Bourla at Davos regarding vaccine transmission claims. Friedberg warns about platform downranking while Sacks defends press questioning.44:24–48:56 · The hosts as informed peer 9/10 Medical Studies on Vaccine Safety & Myocarditis Risks Friedberg breaks down a Mass General study published in Circulation demonstrating that uncleared spike protein in blood correlates with myocarditis cases in young men. Sacks probes the timeline and safety risks compared to French Nature studies.48:56–51:56 · The hosts as informed peer 6/10 Vaccine Mandates, Media Pressure, and Efficacy Questions Sacks questions whether Joe Rogan was prematurely vilified for opposing young adult vaccination, while Calacanis reflects on travel mandates driving personal choices. Sacks stresses the intense social and legal coercion present in 2021.51:56–57:51 · The hosts as informed peer 9/10 FDA Approval Pathways, Emergency Use Authorization, and Myocarditis Research Chamath outlines FDA approval pathways, contrasting 12-year standard drug timelines with Emergency Use Authorization (EUA) shortcuts for mRNA vaccines, citing his own co-authored cardiology paper on troponin spikes.57:51–1:03:50 · The hosts as informed peer 7/10 Institutional Trust, Mandate Controversies, and Personal Regrets Friedberg highlights post-activity rationalization by public health officials that broke institutional trust. Sacks presses Calacanis on whether elites suffered from groupthink regarding lockdowns and mandates.1:03:50–1:12:16 · The hosts as informed peer 7/10 Debating Past Vaccine Tweets, Booster Efficacy, and Pharma Incentives Sacks confronts Calacanis by reading a January 2022 tweet where Calacanis accused Fox News and Trump of killing constituents with anti-vax sentiment. Calacanis vigorously defends his post before all four hosts agree they will decline future boosters.1:12:16–1:22:39 · The hosts as informed peer 8/10 Escalation in Ukraine, Tank Deliveries, and Reconstruction Costs Sacks outlines Ukraine escalation, citing Abrams tank deliveries and Larry Fink's $750B reconstruction estimate. Friedberg details Russian tactical nuclear doctrine risks while Chamath and Calacanis call for an exit ramp.1:22:39–1:33:24 · The hosts as informed peer 10/10 Science Corner: Epigenetics, Yamanaka Factors, and Reversing Aging Friedberg presents a Harvard study on the epigenome and information theory of aging, explaining how DNA breaks degrade cellular software and how Yamanaka factors reset gene expression. Sacks and Chamath ask about practical clinical horizons.2:51–6:56 · Guest teaching 4/10 DOJ Lawsuit to Break Up Google's Ad Tech Business Chamath details digital ad market shares (Google 26.5%, Meta 18.4%, Amazon 11.7%, Others 43.4%), contrasting Google's position with Ma Bell's 1980s 100% monopoly to argue the DOJ lawsuit is ill-founded. Sacks moderates by raising the antitrust filing, while Chamath provides detailed market analysis.6:56–12:12 · Guest teaching 7/10 Friedberg's Analysis of Google's Auction Model & Publisher Payouts Friedberg draws on his AdSense and AdWords experience since 2002 to explain how Google's auction model and 70-80% publisher revenue share prevent monopoly rents. Sacks uses a DOJ diagram to probe sell-side vs buy-side market concentration.12:12–15:16 · Guest teaching 3/10 Government Unwinding Decade-Old Deals & Impact on M&A Calacanis, Sacks, and Chamath critique the DOJ trying to unwind DoubleClick fifteen years post-acquisition, noting it creates market uncertainty and chills tech M&A.15:16–17:53 · Guest teaching 6/10 Shifting Ad Market Dynamics: Amazon, Third-Party Cookies & Apple IDFA Friedberg outlines how Amazon's e-commerce ad growth, Apple's IDFA deprecation, and 2024 third-party cookie removal are naturally decentralizing ad spend. Chamath highlights these shifts as evidence of dynamic market self-regulation.17:53–23:07 · Guest teaching 4/10 Monopolistic Targets: App Store Duopolies vs. Regulatory Misdirection Chamath forcefully pushes back when Calacanis draws an analogy to Xi Jinping and Jack Ma, calling out Calacanis for virtue signaling about China. Sacks and Chamath argue regulators should focus on true duopolies like Apple and Google's app stores.23:07–25:37 · Guest teaching 6/10 EU Antitrust Probe into Microsoft Teams & Slack's Complaint Chamath shares insider perspective from his time on Slack's board during its IPO, explaining how Microsoft Teams used distribution bundling to counter Slack's superior product. Sacks introduces the EU antitrust probe into Microsoft bundling.25:37–29:41 · Guest teaching 4/10 Predatory Bundling, ELAs & Sacks' Unbundling Proposal Sacks argues Microsoft's enterprise bundling degrades startup moats in B2B software, while Chamath suggests regulatory transparency for Enterprise Licensing Agreements (ELAs). Calacanis questions whether consumers suffer actual harm.29:41–33:38 · Guest teaching 6/10 The Software Dumping Debate: Free Market vs. Antitrust Protections Friedberg strongly rejects Sacks' framing that bundling constitutes software dumping, arguing that superior differentiated software will win regardless of discounts. Sacks counters that software reverse engineering makes bundling inherently predatory.33:38–38:03 · Guest teaching 5/10 SaaS Innovation Moats & The Comcast / Netflix Analogy Chamath challenges Friedberg using a Comcast and Netflix analogy to show how distribution rails can smother application innovation. Sacks compares software bundling to Chinese steel dumping to justify regulatory oversight.38:03–40:34 · Guest teaching 5/10 Practical Regulatory Remedies for B2B Software Markets Chamath outlines regulatory remedies including transfer-pricing transparency and sum-of-the-parts pricing rules, drawing parallels to Pfizer's healthcare R&D accounting mandates.40:34–44:24 · Guest teaching 4/10 Pfizer CEO Albert Bourla Confronted at Davos by Rebel News Sacks plays a video clip of a Rebel News reporter aggressively questioning Pfizer CEO Albert Bourla at Davos regarding vaccine transmission claims. Friedberg warns about platform downranking while Sacks defends press questioning.44:24–48:56 · Guest teaching 8/10 Medical Studies on Vaccine Safety & Myocarditis Risks Friedberg breaks down a Mass General study published in Circulation demonstrating that uncleared spike protein in blood correlates with myocarditis cases in young men. Sacks probes the timeline and safety risks compared to French Nature studies.48:56–51:56 · Guest teaching 4/10 Vaccine Mandates, Media Pressure, and Efficacy Questions Sacks questions whether Joe Rogan was prematurely vilified for opposing young adult vaccination, while Calacanis reflects on travel mandates driving personal choices. Sacks stresses the intense social and legal coercion present in 2021.51:56–57:51 · Guest teaching 8/10 FDA Approval Pathways, Emergency Use Authorization, and Myocarditis Research Chamath outlines FDA approval pathways, contrasting 12-year standard drug timelines with Emergency Use Authorization (EUA) shortcuts for mRNA vaccines, citing his own co-authored cardiology paper on troponin spikes.57:51–1:03:50 · Guest teaching 5/10 Institutional Trust, Mandate Controversies, and Personal Regrets Friedberg highlights post-activity rationalization by public health officials that broke institutional trust. Sacks presses Calacanis on whether elites suffered from groupthink regarding lockdowns and mandates.1:03:50–1:12:16 · Guest teaching 5/10 Debating Past Vaccine Tweets, Booster Efficacy, and Pharma Incentives Sacks confronts Calacanis by reading a January 2022 tweet where Calacanis accused Fox News and Trump of killing constituents with anti-vax sentiment. Calacanis vigorously defends his post before all four hosts agree they will decline future boosters.1:12:16–1:22:39 · Guest teaching 6/10 Escalation in Ukraine, Tank Deliveries, and Reconstruction Costs Sacks outlines Ukraine escalation, citing Abrams tank deliveries and Larry Fink's $750B reconstruction estimate. Friedberg details Russian tactical nuclear doctrine risks while Chamath and Calacanis call for an exit ramp.1:22:39–1:33:24 · Guest teaching 9/10 Science Corner: Epigenetics, Yamanaka Factors, and Reversing Aging Friedberg presents a Harvard study on the epigenome and information theory of aging, explaining how DNA breaks degrade cellular software and how Yamanaka factors reset gene expression. Sacks and Chamath ask about practical clinical horizons.2:51–6:56 · Guest disagreement 3/10 DOJ Lawsuit to Break Up Google's Ad Tech Business Chamath details digital ad market shares (Google 26.5%, Meta 18.4%, Amazon 11.7%, Others 43.4%), contrasting Google's position with Ma Bell's 1980s 100% monopoly to argue the DOJ lawsuit is ill-founded. Sacks moderates by raising the antitrust filing, while Chamath provides detailed market analysis.6:56–12:12 · Guest disagreement 2/10 Friedberg's Analysis of Google's Auction Model & Publisher Payouts Friedberg draws on his AdSense and AdWords experience since 2002 to explain how Google's auction model and 70-80% publisher revenue share prevent monopoly rents. Sacks uses a DOJ diagram to probe sell-side vs buy-side market concentration.12:12–15:16 · Guest disagreement 2/10 Government Unwinding Decade-Old Deals & Impact on M&A Calacanis, Sacks, and Chamath critique the DOJ trying to unwind DoubleClick fifteen years post-acquisition, noting it creates market uncertainty and chills tech M&A.15:16–17:53 · Guest disagreement 1/10 Shifting Ad Market Dynamics: Amazon, Third-Party Cookies & Apple IDFA Friedberg outlines how Amazon's e-commerce ad growth, Apple's IDFA deprecation, and 2024 third-party cookie removal are naturally decentralizing ad spend. Chamath highlights these shifts as evidence of dynamic market self-regulation.17:53–23:07 · Guest disagreement 6/10 Monopolistic Targets: App Store Duopolies vs. Regulatory Misdirection Chamath forcefully pushes back when Calacanis draws an analogy to Xi Jinping and Jack Ma, calling out Calacanis for virtue signaling about China. Sacks and Chamath argue regulators should focus on true duopolies like Apple and Google's app stores.23:07–25:37 · Guest disagreement 2/10 EU Antitrust Probe into Microsoft Teams & Slack's Complaint Chamath shares insider perspective from his time on Slack's board during its IPO, explaining how Microsoft Teams used distribution bundling to counter Slack's superior product. Sacks introduces the EU antitrust probe into Microsoft bundling.25:37–29:41 · Guest disagreement 4/10 Predatory Bundling, ELAs & Sacks' Unbundling Proposal Sacks argues Microsoft's enterprise bundling degrades startup moats in B2B software, while Chamath suggests regulatory transparency for Enterprise Licensing Agreements (ELAs). Calacanis questions whether consumers suffer actual harm.29:41–33:38 · Guest disagreement 7/10 The Software Dumping Debate: Free Market vs. Antitrust Protections Friedberg strongly rejects Sacks' framing that bundling constitutes software dumping, arguing that superior differentiated software will win regardless of discounts. Sacks counters that software reverse engineering makes bundling inherently predatory.33:38–38:03 · Guest disagreement 7/10 SaaS Innovation Moats & The Comcast / Netflix Analogy Chamath challenges Friedberg using a Comcast and Netflix analogy to show how distribution rails can smother application innovation. Sacks compares software bundling to Chinese steel dumping to justify regulatory oversight.38:03–40:34 · Guest disagreement 2/10 Practical Regulatory Remedies for B2B Software Markets Chamath outlines regulatory remedies including transfer-pricing transparency and sum-of-the-parts pricing rules, drawing parallels to Pfizer's healthcare R&D accounting mandates.40:34–44:24 · Guest disagreement 8/10 Pfizer CEO Albert Bourla Confronted at Davos by Rebel News Sacks plays a video clip of a Rebel News reporter aggressively questioning Pfizer CEO Albert Bourla at Davos regarding vaccine transmission claims. Friedberg warns about platform downranking while Sacks defends press questioning.44:24–48:56 · Guest disagreement 2/10 Medical Studies on Vaccine Safety & Myocarditis Risks Friedberg breaks down a Mass General study published in Circulation demonstrating that uncleared spike protein in blood correlates with myocarditis cases in young men. Sacks probes the timeline and safety risks compared to French Nature studies.48:56–51:56 · Guest disagreement 3/10 Vaccine Mandates, Media Pressure, and Efficacy Questions Sacks questions whether Joe Rogan was prematurely vilified for opposing young adult vaccination, while Calacanis reflects on travel mandates driving personal choices. Sacks stresses the intense social and legal coercion present in 2021.51:56–57:51 · Guest disagreement 2/10 FDA Approval Pathways, Emergency Use Authorization, and Myocarditis Research Chamath outlines FDA approval pathways, contrasting 12-year standard drug timelines with Emergency Use Authorization (EUA) shortcuts for mRNA vaccines, citing his own co-authored cardiology paper on troponin spikes.57:51–1:03:50 · Guest disagreement 5/10 Institutional Trust, Mandate Controversies, and Personal Regrets Friedberg highlights post-activity rationalization by public health officials that broke institutional trust. Sacks presses Calacanis on whether elites suffered from groupthink regarding lockdowns and mandates.1:03:50–1:12:16 · Guest disagreement 7/10 Debating Past Vaccine Tweets, Booster Efficacy, and Pharma Incentives Sacks confronts Calacanis by reading a January 2022 tweet where Calacanis accused Fox News and Trump of killing constituents with anti-vax sentiment. Calacanis vigorously defends his post before all four hosts agree they will decline future boosters.1:12:16–1:22:39 · Guest disagreement 4/10 Escalation in Ukraine, Tank Deliveries, and Reconstruction Costs Sacks outlines Ukraine escalation, citing Abrams tank deliveries and Larry Fink's $750B reconstruction estimate. Friedberg details Russian tactical nuclear doctrine risks while Chamath and Calacanis call for an exit ramp.1:22:39–1:33:24 · Guest disagreement 2/10 Science Corner: Epigenetics, Yamanaka Factors, and Reversing Aging Friedberg presents a Harvard study on the epigenome and information theory of aging, explaining how DNA breaks degrade cellular software and how Yamanaka factors reset gene expression. Sacks and Chamath ask about practical clinical horizons.2:51–6:56 · The hosts pushing back 4/10 DOJ Lawsuit to Break Up Google's Ad Tech Business Chamath details digital ad market shares (Google 26.5%, Meta 18.4%, Amazon 11.7%, Others 43.4%), contrasting Google's position with Ma Bell's 1980s 100% monopoly to argue the DOJ lawsuit is ill-founded. Sacks moderates by raising the antitrust filing, while Chamath provides detailed market analysis.6:56–12:12 · The hosts pushing back 5/10 Friedberg's Analysis of Google's Auction Model & Publisher Payouts Friedberg draws on his AdSense and AdWords experience since 2002 to explain how Google's auction model and 70-80% publisher revenue share prevent monopoly rents. Sacks uses a DOJ diagram to probe sell-side vs buy-side market concentration.12:12–15:16 · The hosts pushing back 4/10 Government Unwinding Decade-Old Deals & Impact on M&A Calacanis, Sacks, and Chamath critique the DOJ trying to unwind DoubleClick fifteen years post-acquisition, noting it creates market uncertainty and chills tech M&A.15:16–17:53 · The hosts pushing back 3/10 Shifting Ad Market Dynamics: Amazon, Third-Party Cookies & Apple IDFA Friedberg outlines how Amazon's e-commerce ad growth, Apple's IDFA deprecation, and 2024 third-party cookie removal are naturally decentralizing ad spend. Chamath highlights these shifts as evidence of dynamic market self-regulation.17:53–23:07 · The hosts pushing back 6/10 Monopolistic Targets: App Store Duopolies vs. Regulatory Misdirection Chamath forcefully pushes back when Calacanis draws an analogy to Xi Jinping and Jack Ma, calling out Calacanis for virtue signaling about China. Sacks and Chamath argue regulators should focus on true duopolies like Apple and Google's app stores.23:07–25:37 · The hosts pushing back 4/10 EU Antitrust Probe into Microsoft Teams & Slack's Complaint Chamath shares insider perspective from his time on Slack's board during its IPO, explaining how Microsoft Teams used distribution bundling to counter Slack's superior product. Sacks introduces the EU antitrust probe into Microsoft bundling.25:37–29:41 · The hosts pushing back 6/10 Predatory Bundling, ELAs & Sacks' Unbundling Proposal Sacks argues Microsoft's enterprise bundling degrades startup moats in B2B software, while Chamath suggests regulatory transparency for Enterprise Licensing Agreements (ELAs). Calacanis questions whether consumers suffer actual harm.29:41–33:38 · The hosts pushing back 7/10 The Software Dumping Debate: Free Market vs. Antitrust Protections Friedberg strongly rejects Sacks' framing that bundling constitutes software dumping, arguing that superior differentiated software will win regardless of discounts. Sacks counters that software reverse engineering makes bundling inherently predatory.33:38–38:03 · The hosts pushing back 7/10 SaaS Innovation Moats & The Comcast / Netflix Analogy Chamath challenges Friedberg using a Comcast and Netflix analogy to show how distribution rails can smother application innovation. Sacks compares software bundling to Chinese steel dumping to justify regulatory oversight.38:03–40:34 · The hosts pushing back 4/10 Practical Regulatory Remedies for B2B Software Markets Chamath outlines regulatory remedies including transfer-pricing transparency and sum-of-the-parts pricing rules, drawing parallels to Pfizer's healthcare R&D accounting mandates.40:34–44:24 · The hosts pushing back 6/10 Pfizer CEO Albert Bourla Confronted at Davos by Rebel News Sacks plays a video clip of a Rebel News reporter aggressively questioning Pfizer CEO Albert Bourla at Davos regarding vaccine transmission claims. Friedberg warns about platform downranking while Sacks defends press questioning.44:24–48:56 · The hosts pushing back 5/10 Medical Studies on Vaccine Safety & Myocarditis Risks Friedberg breaks down a Mass General study published in Circulation demonstrating that uncleared spike protein in blood correlates with myocarditis cases in young men. Sacks probes the timeline and safety risks compared to French Nature studies.48:56–51:56 · The hosts pushing back 6/10 Vaccine Mandates, Media Pressure, and Efficacy Questions Sacks questions whether Joe Rogan was prematurely vilified for opposing young adult vaccination, while Calacanis reflects on travel mandates driving personal choices. Sacks stresses the intense social and legal coercion present in 2021.51:56–57:51 · The hosts pushing back 4/10 FDA Approval Pathways, Emergency Use Authorization, and Myocarditis Research Chamath outlines FDA approval pathways, contrasting 12-year standard drug timelines with Emergency Use Authorization (EUA) shortcuts for mRNA vaccines, citing his own co-authored cardiology paper on troponin spikes.57:51–1:03:50 · The hosts pushing back 7/10 Institutional Trust, Mandate Controversies, and Personal Regrets Friedberg highlights post-activity rationalization by public health officials that broke institutional trust. Sacks presses Calacanis on whether elites suffered from groupthink regarding lockdowns and mandates.1:03:50–1:12:16 · The hosts pushing back 8/10 Debating Past Vaccine Tweets, Booster Efficacy, and Pharma Incentives Sacks confronts Calacanis by reading a January 2022 tweet where Calacanis accused Fox News and Trump of killing constituents with anti-vax sentiment. Calacanis vigorously defends his post before all four hosts agree they will decline future boosters.1:12:16–1:22:39 · The hosts pushing back 6/10 Escalation in Ukraine, Tank Deliveries, and Reconstruction Costs Sacks outlines Ukraine escalation, citing Abrams tank deliveries and Larry Fink's $750B reconstruction estimate. Friedberg details Russian tactical nuclear doctrine risks while Chamath and Calacanis call for an exit ramp.1:22:39–1:33:24 · The hosts pushing back 4/10 Science Corner: Epigenetics, Yamanaka Factors, and Reversing Aging Friedberg presents a Harvard study on the epigenome and information theory of aging, explaining how DNA breaks degrade cellular software and how Yamanaka factors reset gene expression. Sacks and Chamath ask about practical clinical horizons.

speaking balance: gold is the hosts, purple is the guest (3 minute bins)

0:00 · the hosts 100% · guest 0%0:00 · the hosts 100% · guest 0%3:00 · the hosts 100% · guest 0%3:00 · the hosts 100% · guest 0%6:00 · the hosts 100% · guest 0%6:00 · the hosts 100% · guest 0%9:00 · the hosts 100% · guest 0%9:00 · the hosts 100% · guest 0%12:00 · the hosts 100% · guest 0%12:00 · the hosts 100% · guest 0%15:00 · the hosts 99.9% · guest 0.1%15:00 · the hosts 99.9% · guest 0.1%18:00 · the hosts 100% · guest 0%18:00 · the hosts 100% · guest 0%21:00 · the hosts 100% · guest 0%21:00 · the hosts 100% · guest 0%24:00 · the hosts 100% · guest 0%24:00 · the hosts 100% · guest 0%27:00 · the hosts 100% · guest 0%27:00 · the hosts 100% · guest 0%30:00 · the hosts 100% · guest 0%30:00 · the hosts 100% · guest 0%33:00 · the hosts 100% · guest 0%33:00 · the hosts 100% · guest 0%36:00 · the hosts 100% · guest 0%36:00 · the hosts 100% · guest 0%39:00 · the hosts 79.8% · guest 20.2%39:00 · the hosts 79.8% · guest 20.2%42:00 · the hosts 100% · guest 0%42:00 · the hosts 100% · guest 0%45:00 · the hosts 100% · guest 0%45:00 · the hosts 100% · guest 0%48:00 · the hosts 100% · guest 0%48:00 · the hosts 100% · guest 0%51:00 · the hosts 100% · guest 0%51:00 · the hosts 100% · guest 0%54:00 · the hosts 100% · guest 0%54:00 · the hosts 100% · guest 0%57:00 · the hosts 100% · guest 0%57:00 · the hosts 100% · guest 0%1:00:00 · the hosts 100% · guest 0%1:00:00 · the hosts 100% · guest 0%1:03:00 · the hosts 100% · guest 0%1:03:00 · the hosts 100% · guest 0%1:06:00 · the hosts 99.9% · guest 0.1%1:06:00 · the hosts 99.9% · guest 0.1%1:09:00 · the hosts 99.7% · guest 0.3%1:09:00 · the hosts 99.7% · guest 0.3%1:12:00 · the hosts 100% · guest 0%1:12:00 · the hosts 100% · guest 0%1:15:00 · the hosts 100% · guest 0%1:15:00 · the hosts 100% · guest 0%1:18:00 · the hosts 100% · guest 0%1:18:00 · the hosts 100% · guest 0%1:21:00 · the hosts 100% · guest 0%1:21:00 · the hosts 100% · guest 0%1:24:00 · the hosts 100% · guest 0%1:24:00 · the hosts 100% · guest 0%1:27:00 · the hosts 100% · guest 0%1:27:00 · the hosts 100% · guest 0%1:30:00 · the hosts 100% · guest 0%1:30:00 · the hosts 100% · guest 0%1:33:00 · the hosts 98.3% · guest 1.7%1:33:00 · the hosts 98.3% · guest 1.7%1:36:00 · the hosts 80.5% · guest 19.5%1:36:00 · the hosts 80.5% · guest 19.5%
Sharpest disagreement ▶ 41:10 Rebel News reporter grills Pfizer CEO Albert Bourla

The reporter relentlessly follows Pfizer CEO Albert Bourla through the streets of Davos, repeatedly rejecting his evasions and demanding to know why Pfizer kept vaccine transmission limits secret.

Hardest push from the hosts ▶ 1:03:50 Sacks confronts Calacanis with his Jan 2022 vaccine tweet

Sacks directly refuses Calacanis's reframe that he never supported vaccine coercion, reading Calacanis's own tweet aloud to expose inconsistency and force a direct defense.

Biggest teaching moment ▶ 1:26:20 Friedberg educates panel on epigenetics and Yamanaka factors

Friedberg provides an authoritative biology masterclass on the information theory of aging, teaching the co-hosts how epigenetic degradation rather than DNA mutation drives cellular aging.

The host holds their own ▶ 4:03 Chamath dismantles DOJ monopoly framing with ad market share data

Chamath demonstrates expert domain knowledge by citing granular digital ad market statistics to prove Google lacks classic monopoly concentration compared to 1980s Ma Bell.

the scores for every segment, with the reasoning behind each
ChapterTopicThe hosts as informed peerGuest teachingGuest disagreementThe hosts pushing backWhy
DOJ Lawsuit to Break Up Google's Ad Tech Business 8434 Chamath details digital ad market shares (Google 26.5%, Meta 18.4%, Amazon 11.7%, Others 43.4%), contrasting Google's position with Ma Bell's 1980s 100% monopoly to argue the DOJ lawsuit is ill-founded. Sacks moderates by raising the antitrust filing, while Chamath provides detailed market analysis.
Friedberg's Analysis of Google's Auction Model & Publisher Payouts 9725 Friedberg draws on his AdSense and AdWords experience since 2002 to explain how Google's auction model and 70-80% publisher revenue share prevent monopoly rents. Sacks uses a DOJ diagram to probe sell-side vs buy-side market concentration.
Government Unwinding Decade-Old Deals & Impact on M&A 6324 Calacanis, Sacks, and Chamath critique the DOJ trying to unwind DoubleClick fifteen years post-acquisition, noting it creates market uncertainty and chills tech M&A.
Shifting Ad Market Dynamics: Amazon, Third-Party Cookies & Apple IDFA 8613 Friedberg outlines how Amazon's e-commerce ad growth, Apple's IDFA deprecation, and 2024 third-party cookie removal are naturally decentralizing ad spend. Chamath highlights these shifts as evidence of dynamic market self-regulation.
Monopolistic Targets: App Store Duopolies vs. Regulatory Misdirection 7466 Chamath forcefully pushes back when Calacanis draws an analogy to Xi Jinping and Jack Ma, calling out Calacanis for virtue signaling about China. Sacks and Chamath argue regulators should focus on true duopolies like Apple and Google's app stores.
EU Antitrust Probe into Microsoft Teams & Slack's Complaint 8624 Chamath shares insider perspective from his time on Slack's board during its IPO, explaining how Microsoft Teams used distribution bundling to counter Slack's superior product. Sacks introduces the EU antitrust probe into Microsoft bundling.
Predatory Bundling, ELAs & Sacks' Unbundling Proposal 7446 Sacks argues Microsoft's enterprise bundling degrades startup moats in B2B software, while Chamath suggests regulatory transparency for Enterprise Licensing Agreements (ELAs). Calacanis questions whether consumers suffer actual harm.
The Software Dumping Debate: Free Market vs. Antitrust Protections 7677 Friedberg strongly rejects Sacks' framing that bundling constitutes software dumping, arguing that superior differentiated software will win regardless of discounts. Sacks counters that software reverse engineering makes bundling inherently predatory.
SaaS Innovation Moats & The Comcast / Netflix Analogy 8577 Chamath challenges Friedberg using a Comcast and Netflix analogy to show how distribution rails can smother application innovation. Sacks compares software bundling to Chinese steel dumping to justify regulatory oversight.
Practical Regulatory Remedies for B2B Software Markets 8524 Chamath outlines regulatory remedies including transfer-pricing transparency and sum-of-the-parts pricing rules, drawing parallels to Pfizer's healthcare R&D accounting mandates.
Pfizer CEO Albert Bourla Confronted at Davos by Rebel News 6486 Sacks plays a video clip of a Rebel News reporter aggressively questioning Pfizer CEO Albert Bourla at Davos regarding vaccine transmission claims. Friedberg warns about platform downranking while Sacks defends press questioning.
Medical Studies on Vaccine Safety & Myocarditis Risks 9825 Friedberg breaks down a Mass General study published in Circulation demonstrating that uncleared spike protein in blood correlates with myocarditis cases in young men. Sacks probes the timeline and safety risks compared to French Nature studies.
Vaccine Mandates, Media Pressure, and Efficacy Questions 6436 Sacks questions whether Joe Rogan was prematurely vilified for opposing young adult vaccination, while Calacanis reflects on travel mandates driving personal choices. Sacks stresses the intense social and legal coercion present in 2021.
FDA Approval Pathways, Emergency Use Authorization, and Myocarditis Research 9824 Chamath outlines FDA approval pathways, contrasting 12-year standard drug timelines with Emergency Use Authorization (EUA) shortcuts for mRNA vaccines, citing his own co-authored cardiology paper on troponin spikes.
Institutional Trust, Mandate Controversies, and Personal Regrets 7557 Friedberg highlights post-activity rationalization by public health officials that broke institutional trust. Sacks presses Calacanis on whether elites suffered from groupthink regarding lockdowns and mandates.
Debating Past Vaccine Tweets, Booster Efficacy, and Pharma Incentives 7578 Sacks confronts Calacanis by reading a January 2022 tweet where Calacanis accused Fox News and Trump of killing constituents with anti-vax sentiment. Calacanis vigorously defends his post before all four hosts agree they will decline future boosters.
Escalation in Ukraine, Tank Deliveries, and Reconstruction Costs 8646 Sacks outlines Ukraine escalation, citing Abrams tank deliveries and Larry Fink's $750B reconstruction estimate. Friedberg details Russian tactical nuclear doctrine risks while Chamath and Calacanis call for an exit ramp.
Science Corner: Epigenetics, Yamanaka Factors, and Reversing Aging 10924 Friedberg presents a Harvard study on the epigenome and information theory of aging, explaining how DNA breaks degrade cellular software and how Yamanaka factors reset gene expression. Sacks and Chamath ask about practical clinical horizons.

Statements from this episode (40)

Assertion Supported
Sacks: Doomsday Clock is closer to midnight than during Cold War
“The famous doomsday clock that atomic scientists use to measure the threat of nuclear annihilation has never been closer to midnight, not even during the Cold War.”
David Sacks Jan 27, 2023 ▶ 1:15
Opinion
Chamath: DOJ antitrust lawsuit against Google is ill-founded and anti-entrepreneur
“Yeah, I think that this is a totally ill-founded lawsuit, and I think it just shows more of the personal enmity and anger that some people in the US government has towards entrepreneurs and entrepreneurship than anything else.”
Chamath Palihapitiya Jan 27, 2023 ▶ 4:03
Assertion Partly supported
Chamath Palihapitiya cites market data showing Google holds 26.5% of digital ads
“Google controls 26.5% of a market. 43.4% of that market is with a diverse group of others. Meta has 18.4%, and Amazon has 11.7.”
Chamath Palihapitiya Jan 27, 2023 ▶ 4:47
What-if
Chamath: US government should have targeted Google search instead of ad tech
“If I were the US government, I would have actually focused on search because search is a monopoly for Google.”
Chamath Palihapitiya Jan 27, 2023 ▶ 6:06
Prediction Didn’t hold up
Chamath predicts the DOJ antitrust lawsuit against Google will fail
“But by focusing on this, I think it's going to get deconstructed. It's going to fail.”
Chamath Palihapitiya Jan 27, 2023 ▶ 6:36
Insight
Friedberg: Ad auctions reach competitive pricing with only a few dozen advertisers
“But I will tell you that when you get to a certain volume, and it's not a big volume, you don't need a million advertisers bidding against each other. You only need a few dozen advertisers. And once you have a few dozen advertisers bidding against each other, …”
David Friedberg Jan 27, 2023 ▶ 10:44
Prediction Not checkable as stated
Friedberg: Breaking up Google's ad business will cause publishers to earn less
“And if you try and break this up, and if you actually do try and, you know, get into the weeds of this whole system and change it, the publishers ultimately will make less money.”
David Friedberg Jan 27, 2023 ▶ 11:06
Opinion
Calacanis: Google exhibits monopoly behavior in search by self-preferencing
“No, I, there is monopoly behavior going on at Google, obviously, with search and putting their own content and services up top, and to Shemad's point, like, that's probably the easier target.”
Jason Calacanis Jan 27, 2023 ▶ 12:13
Insight
Sacks: Unwinding approved acquisitions creates market uncertainty and chills M&A
“I think it's a pretty bad way to approach things because they create so much uncertainty in the marketplace and has a chilling effect on future acquisitions. Yeah. Like when you get approval from the government, you want to know you're good. And we have an app…”
David Sacks Jan 27, 2023 ▶ 13:45
Opinion
Chamath: DOJ antitrust suits contort law instead of updating legislation
“I just feel these lawsuits right now are bordering on the mean spirited because these things have been tried. They've generally failed. And so the real solution, it always goes back to this and it's, Ugly and messy is you need to rewrite the actual laws to ref…”
Chamath Palihapitiya Jan 27, 2023 ▶ 14:32
Disclosure
Friedberg: Portfolio companies moved ad spend from Google and Meta to Amazon
“I know this from experience on a couple boards. I'm at where companies stopped spending on Facebook and Google and just started spending exclusively on Amazon.”
David Friedberg Jan 27, 2023 ▶ 16:19
Assertion Partly supported
Calacanis: Uber's ad business made $350M in year one
“And then you may have noticed Uber's doing an ad business now. They did three hundred fifty million dollars in the first year of that business, a million a day, and they're projected to do a billion next year.”
Jason Calacanis Jan 27, 2023 ▶ 20:39
Opinion
Chamath: Apple and Google hold app store duopoly and search monopoly
“And so domestically in the United States and Western Europe, there's a de facto duopoly, complete control, completely inflexible, inelastic pricing. That is a monopoly. And then separately for search in the United States, it is also an effective monopoly.”
Chamath Palihapitiya Jan 27, 2023 ▶ 22:39
Opinion
Chamath: Microsoft bundling Teams was anti-competitive, but not monopolistic
“I think what Microsoft did was anti-competitive, but I don't think it was monopolistic.”
Chamath Palihapitiya Jan 27, 2023 ▶ 24:13
Assertion Not checkable as stated
Chamath: Microsoft forced Slack into acquisition by Salesforce
“And in many ways, David, it forced the hand of Slack to be acquired by Salesforce.”
Chamath Palihapitiya Jan 27, 2023 ▶ 25:15
Opinion
Sacks: Microsoft clones products from Slack, Okta, and Zoom to weaken them
“If Microsoft can basically clone the sort of the breakthrough innovative product, you know, just to say they do one every year and then they put a crappy version of that in their bundle. Yeah. Yeah. Yeah. 10% or 50% worse, but they give it away effectively for…”
David Sacks Jan 27, 2023 ▶ 25:37
Assertion Supported
Calacanis: Slack's percentage growth rate inside Salesforce matched its independent growth rate
“And if you look at Slack itself, it's still growing the same percentage growth it did inside of Salesforce that it did as an independent company. So it's growing at a similar pace.”
Jason Calacanis Jan 27, 2023 ▶ 27:16
Opinion
Chamath: LinkedIn is the only $20B+ tech acquisition that succeeded
“The only one of that scale that's really worked out definitively has been LinkedIn.”
Chamath Palihapitiya Jan 27, 2023 ▶ 28:06
Opinion
Sacks: Tech incumbent software bundling is a form of economic dumping
“I think that this bundling behavior is a form of dumping where in the short run, it looks like consumers are benefiting because they're getting zoom, a zoom clone for free or, you know, a slack clone for free. But then what happens is once they've, you know, h…”
David Sacks Jan 27, 2023 ▶ 30:31
Opinion
Sacks: Regulators should mandate itemized individual pricing for software bundles
“What you need to do is require that when they create a bundle, every product in that bundle needs to basically have an individual price. And the price of every product in that bundle should add up to the cost of the bundle.”
David Sacks Jan 27, 2023 ▶ 30:58
Opinion
Friedberg: Superior software products will overcome free incumbent bundles
“If your product is actually better, and it provides better ROI for the customer, it has a better feature set, it's faster, it has a bunch of stuff that the other product doesn't have, the market will pick it.”
David Friedberg Jan 27, 2023 ▶ 33:18
Insight
Chamath: Application-layer enterprise software has little lock-in and is easily copied
“There's very little lock in at the application layer. So workflow apps, which effectively is what most of these enterprise software things are. Are very copyable because there's nothing that really locks it in.”
Chamath Palihapitiya Jan 27, 2023 ▶ 34:38
Opinion
Chamath: Enterprise tech bundling is too complex for government regulation
“I think it's too complicated for a government to understand.”
Chamath Palihapitiya Jan 27, 2023 ▶ 38:47
Prediction Not checkable as stated
Chamath: Licensing transparency would stop big tech software dumping
“I think the combination of what David said and I said would do the trick, which is if you force these highly complicated licensing agreements to be transparent, it would not allow them to dump.”
Chamath Palihapitiya Jan 27, 2023 ▶ 39:17
Assertion Contradicted
Sacks claims YouTube removed the viral Pfizer CEO Davos clip
“YouTube banned that video. We had to watch it on Twitter because Elon Musk's Twitter is still free.”
David Sacks Jan 27, 2023 ▶ 42:16
Assertion Supported
Friedberg estimates Pfizer making $10B-$15B from COVID vaccine in 2023
“I think they're making 10 to fifteen billion dollars on this vaccine this year.”
David Friedberg Jan 27, 2023 ▶ 43:17
Assertion Supported
Friedberg: COVID transmission rates among vaccinated people rose as virus mutated
“As this virus evolved and mutated, it became pretty evident pretty fast that the rate of Transmission in vaccinated people continue to go up.”
David Friedberg Jan 27, 2023 ▶ 43:34
Assertion Supported
Friedberg: Moderna vaccine myocarditis risk up to 30x higher in young people
“The incidence rate is still typically less than two out of every 100,000 people that get the vaccine. But as you saw in the paper you just shared and others have validated it can be as high as 30 times more likely to happen in young people that take the Modern…”
David Friedberg Jan 27, 2023 ▶ 45:59
Assertion Supported
Friedberg: Study finds persistent spike protein in post-vaccine myocarditis patients
“The big difference that they found was that the people that had Myocarditis actually had a lot of the spike protein floating around in their blood, whereas the people that didn't did not have the spike protein floating around in their blood.”
David Friedberg Jan 27, 2023 ▶ 47:31
Opinion
Palihapitiya: A commission should probably investigate COVID vaccine data
“Because of all this, it probably is reasonable to take a step back and have a commission that just uncovers all of this stuff.”
Chamath Palihapitiya Jan 27, 2023 ▶ 57:29
Assertion Not checkable as stated
Friedberg: COVID lockdowns yielded zero benefits while accumulating trillions in costs
“Ultimately, the benefit was zero, because we ended up accumulating, call it 10 trillion dollars of, you know, four trillion dollars of net costs that we have to pay off at some point, not to mention the economic consequences of the lockdowns. And, ah, you know…”
David Friedberg Jan 27, 2023 ▶ 59:26
Prediction Not checkable as stated
Sacks: COVID vaccine mandates will cause broad public distrust of vaccines
“One of the costs of this policy is going to be that people will stop trusting vaccination in general”
David Sacks Jan 27, 2023 ▶ 1:00:39
Disclosure
Sacks: I will not get another COVID booster unless it becomes Ebola
“Unless this virus turns into Ebola, I'm never getting boosted again. I'll tell you that right now.”
David Sacks Jan 27, 2023 ▶ 1:10:45
Opinion
Sacks: COVID face masks became the Democratic equivalent of MAGA hats
“The mask became the blue equivalent of the red MAGA hat.”
David Sacks Jan 27, 2023 ▶ 1:11:34
Assertion Supported
Sacks: Fitch Ratings says Ukraine is headed towards default
“And Fitch ratings agency says that Ukraine is headed towards default.”
David Sacks Jan 27, 2023 ▶ 1:13:14
Prediction Not checkable as stated
Calacanis: Germany will never buy Russian oil again
“The West is never going to trust them again. The Germans are never going to buy their oil again.”
Jason Calacanis Jan 27, 2023 ▶ 1:19:19
Assertion Not checkable as stated
Sacks: The US destroyed Nord Stream and shifted Europe to American gas
“We've prevented Russia from taking over Ukraine. We've prevented, we've basically shifted Europe onto American natural gas. We've destroyed Nord Stream. I think we're close to achieving our major objectives.”
David Sacks Jan 27, 2023 ▶ 1:22:13
Assertion Partly supported
Friedberg: Yamanaka factors increased mouse lifespan by 107%
“And by the way, when they applied those Yamanaka factors to the mice lived a 107% longer than they were supposed to.”
David Friedberg Jan 27, 2023 ▶ 1:30:08
Prediction Not checkable as stated
Friedberg: Investors can profit over 10 years funding longevity biotech trials
“You can make money as an investor over the next 10 years in finding the right teams that are going to have the highest likelihood of progressing clinical trials in this space.”
David Friedberg Jan 27, 2023 ▶ 1:30:44
Prediction Not checkable as stated
Chamath: Epigenetic therapies probably won't impact heart disease anytime soon
“But no, to be honest with you, Saks, the stuff that really can screw you, which is heart disease and brain function, this probably won't do much for a long time.”
Chamath Palihapitiya Jan 27, 2023 ▶ 1:33:06
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 460 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.